These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
843 related items for PubMed ID: 9652742
1. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB. Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742 [Abstract] [Full Text] [Related]
2. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. Oncogene; 1995 Jul 06; 11(1):181-90. PubMed ID: 7624126 [Abstract] [Full Text] [Related]
3. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB. Cell Growth Differ; 1995 Jun 06; 6(6):737-48. PubMed ID: 7669729 [Abstract] [Full Text] [Related]
4. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS. Exp Mol Pathol; 2001 Jun 06; 70(3):183-93. PubMed ID: 11417997 [Abstract] [Full Text] [Related]
5. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schröck E, Dickson RB, Ried T. Genes Chromosomes Cancer; 1999 Jul 06; 25(3):251-60. PubMed ID: 10379871 [Abstract] [Full Text] [Related]
7. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH. Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493 [Abstract] [Full Text] [Related]
8. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E. BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875 [Abstract] [Full Text] [Related]
9. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A. Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691 [Abstract] [Full Text] [Related]
10. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS. Cancer Res; 1993 Jul 15; 53(14):3374-81. PubMed ID: 8324748 [Abstract] [Full Text] [Related]
11. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ. Cancer Res; 1997 Feb 15; 57(4):600-3. PubMed ID: 9044833 [Abstract] [Full Text] [Related]
12. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM, Welsh J. Carcinogenesis; 2004 Dec 15; 25(12):2361-72. PubMed ID: 15333467 [Abstract] [Full Text] [Related]
13. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA. Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935 [Abstract] [Full Text] [Related]
14. A transgenic mouse model for mammary carcinogenesis. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM. Oncogene; 1998 Feb 26; 16(8):997-1007. PubMed ID: 9519874 [Abstract] [Full Text] [Related]
15. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Jäger R, Herzer U, Schenkel J, Weiher H. Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445 [Abstract] [Full Text] [Related]
16. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ. Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828 [Abstract] [Full Text] [Related]
17. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH. Cancer Res; 2001 Sep 01; 61(17):6577-82. PubMed ID: 11522657 [Abstract] [Full Text] [Related]
18. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM. Cancer Res; 1998 Dec 01; 58(23):5500-6. PubMed ID: 9850086 [Abstract] [Full Text] [Related]
19. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB. Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297 [Abstract] [Full Text] [Related]
20. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P. Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]